Yes, thanks, that’s what I meant (voucher not RPD). Can the voucher be transferred to any disease, AD for example or must it be a rare indication? Could 2-73 be granted BTD for Retts and or PDD? If so any thoughts on timeline?
jta, IMO I think it would be wise for Anavex to use it for the AD ph-2b/3 trial because it shortens the time to FDA approval.
Anavex has plenty of cash and no long term debt, so I don't think that they would need to sell it.